Methodhub Software (544637)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 31.09% shows strong capital efficiency
• Latest quarter net profit of ₹10 crore on ₹80 crore sales implies a healthy 12.5% net margin
• P/E of 19.27 is not excessive if profits are sustained
• Software and consulting business appears asset-light, with attractive return on capital employed

Concerns

• Sales growth and profit growth are both 0.00%, indicating a stagnant business
• Piotroski F-Score of 3/9 is very weak and raises doubts about financial health
• No dividend is paid, so investors get no income while waiting for growth
• Missing promoter holding, book value, and debt data make the business hard to evaluate with conviction

AI Analysis

Let me approach this like a business, not a ticker. Methodhub Software sells at ₹117.55, a market cap of ₹222 crore, and a P/E of 19.27. At that multiple, Mr. Market expects steady profits. The trailing earnings implied by the P/E are only around ₹11.5 crore. The latest quarter shows sales of ₹80 crore and net profit of ₹10 crore, so margins are decent, but one quarter is not a franchise. ROCE of 31.09% is genuinely attractive and suggests the business earns well on capital employed. But I see no growth: sales growth and profit growth are both 0.00%. A business with no growth and no dividend should not be bought merely because it is profitable. The Piotroski F-score is 3 out of 9, which rings alarm bells about financial health; I cannot confidently say the company is getting better. There is no book value, no promoter holding figure, no debt-to-equity data. In Graham's discipline, when information is missing, you assume the worst or walk away. I am not willing to pay nineteen times earnings for a zero-growth company whose fundamentals score so poorly. The lack of dividend means the only source of return is price appreciation, and with zero profit growth, that appreciation must come from multiple expansion—a speculative wager. This is a mediocre business at best. If it can sustain 31% ROCE and convert its latest quarter into meaningful yearly growth, I would look again. But as of now, the numbers do not support a margin of safety. I would rather pass and wait for a better bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer